Trusted Global Supplier of Tucatinib 150mg Tablets
Cordium Pharmaceuticals Pvt. Ltd. is a trusted manufacturer and global supplier of Tucatinib 150mg Tablets, delivering high-quality oncology medicines to pharmaceutical distributors, hospitals, cancer clinics, wholesalers, and healthcare institutions across international markets. With a commitment to quality, timely delivery, and customer satisfaction, Cordium Pharmaceuticals serves customers in Washington, California, New York, Dubai, Abu Dhabi, Sharjah, Qatar, Singapore, London, Canada, Australia, Germany, and South Africa.
If you are looking for a reliable Tucatinib 150mg Tablets supplier, Cordium Pharmaceuticals offers dependable pharmaceutical solutions backed by stringent quality standards and global export expertise.
What is Tucatinib 150mg Tablet?
Tucatinib 150mg Tablets are an oral targeted therapy indicated for the treatment of HER2-positive metastatic breast cancer and certain patients with HER2-positive metastatic colorectal cancer, when used in combination with other prescribed anticancer medicines.
Tucatinib is a highly selective HER2 tyrosine kinase inhibitor (TKI) that helps slow the growth and spread of HER2-positive cancer cells while supporting targeted cancer treatment.
Product Details
- Product Name: Tucatinib Tablets
- Strength: 150 mg
- Dosage Form: Oral Tablets
- Category: Oncology Medicine
- Manufacturer: Cordium Pharmaceuticals Pvt. Ltd.
- Prescription: Prescription Only Medicine
Medical Uses of Tucatinib 150mg Tablets
Tucatinib is commonly prescribed for:
- HER2-positive metastatic breast cancer
- HER2-positive breast cancer with brain metastases
- Selected cases of HER2-positive metastatic colorectal cancer
- Combination therapy with trastuzumab and other prescribed medicines
Treatment should always be administered under the supervision of a qualified oncologist.
How Tucatinib Works
Tucatinib selectively targets the HER2 receptor, preventing cancer cells from receiving signals that promote their growth and multiplication.
Benefits include:
- Targeted cancer treatment
- Slower tumor progression
- Improved treatment outcomes in eligible patients
- Effective combination therapy for HER2-positive cancers
Global Supply Locations
Cordium Pharmaceuticals proudly supplies Tucatinib 150mg Tablets to healthcare organizations across:
United States
- Washington
- California
- New York
United Arab Emirates
- Dubai
- Abu Dhabi
- Sharjah
Middle East
- Qatar
Asia-Pacific
- Singapore
- Australia
Europe
- London (United Kingdom)
- Germany
North America
- Canada
Africa
- South Africa
We support:
- Pharmaceutical Distributors
- Oncology Hospitals
- Government Healthcare Agencies
- Cancer Treatment Centers
- Importers & Exporters
- Institutional Procurement Companies
Benefits of Tucatinib 150mg Tablets
- Highly selective HER2 inhibitor
- Oral tablet for convenient administration
- Used in evidence-based combination treatment regimens
- Supports personalized oncology care
- Manufactured under stringent quality standards
Why Choose Cordium Pharmaceuticals Pvt. Ltd.?
Cordium Pharmaceuticals has built a reputation as a trusted global pharmaceutical exporter by consistently delivering quality oncology medicines and dependable service.
Our Advantages
- ✅ Trusted manufacturer of oncology medicines
- ✅ International pharmaceutical export expertise
- ✅ Stringent quality control processes
- ✅ Competitive pricing for bulk and institutional buyers
- ✅ Reliable global logistics and on-time deliveries
- ✅ Professional customer support
- ✅ Long-term partnerships with distributors and healthcare providers
- ✅ Commitment to quality, compliance, and customer satisfaction
Whether you are sourcing for hospitals, pharmacies, or distribution networks, Cordium Pharmaceuticals strives to provide reliable access to high-quality oncology products.
Frequently Asked Questions (FAQs)
1. What is Tucatinib 150mg Tablet used for?
Tucatinib is used in combination with other medicines to treat HER2-positive metastatic breast cancer and certain HER2-positive metastatic colorectal cancers, as determined by an oncologist.
2. Is Tucatinib chemotherapy?
No. Tucatinib is a targeted therapy that specifically inhibits the HER2 receptor rather than acting as traditional chemotherapy.
3. Does Cordium Pharmaceuticals supply Tucatinib internationally?
Yes. Cordium Pharmaceuticals supplies Tucatinib 150mg Tablets to customers in Washington, California, New York, Dubai, Abu Dhabi, Sharjah, Qatar, Singapore, London, Canada, Australia, Germany, South Africa, and additional international markets.
4. Who can purchase Tucatinib from Cordium Pharmaceuticals?
We work with:
- Pharmaceutical importers
- Oncology hospitals
- Licensed distributors
- Government procurement agencies
- Healthcare institutions
- Cancer specialty clinics
Subject to applicable regulatory requirements in the destination market.
5. Is Tucatinib available in 150mg strength?
Yes. Tucatinib is available as 150mg oral tablets, commonly used as part of approved combination treatment regimens.
6. Is a doctor's prescription required?
Yes. Tucatinib is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
7. Why is Cordium Pharmaceuticals a preferred supplier?
Customers choose Cordium Pharmaceuticals because of its focus on quality manufacturing, reliable export capabilities, competitive pricing, responsive customer service, and commitment to supplying high-quality oncology medicines to global healthcare markets.
Conclusion
If you are searching for a trusted supplier of Tucatinib 150mg Tablets in Washington, California, New York, Dubai, Abu Dhabi, Sharjah, Qatar, Singapore, London, Canada, Australia, Germany, or South Africa, Cordium Pharmaceuticals Pvt. Ltd. is committed to supporting healthcare providers and pharmaceutical partners with reliable oncology medicine supply, international export expertise, and consistent product quality.